| |
| |
|
| Insider
Information: |
Crapo James D |
| Relationship: |
CEO, Director |
| City: |
Rtp |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,639,951 |
|
|
Indirect Shares
|
67,000 |
|
|
| Direct
Value |
$4,427,841 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,706,951 |
|
|
| Total
Value |
$4,427,841 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeolus Pharmaceuticals Inc |
AOLS |
Officer |
2004-07-01 |
724,951 |
2004-07-01 |
67,000 |
Premium* |
|
|
Lifevantage Corporation |
LFVN |
Director |
2011-12-13 |
575,000 |
2005-05-16 |
0 |
Premium* |
|
|
Omni Bio Pharmaceutical |
OMBP |
CEO, Director |
2011-06-27 |
340,000 |
2011-02-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LFVN |
Lifevantage Corporation |
Director |
– • – |
2011-12-13 |
4 |
S |
$1.43 |
$114,665 |
D/D |
(80,185) |
575,000 |
0 |
- |
|
| LFVN |
Lifevantage Corporation |
Director |
– • – |
2011-12-07 |
4 |
S |
$1.45 |
$18,250 |
D/D |
(12,556) |
655,185 |
0 |
- |
|
| LFVN |
Lifevantage Corporation |
Director |
– • – |
2011-12-06 |
4 |
S |
$1.43 |
$12,446 |
D/D |
(8,700) |
667,741 |
0 |
- |
|
| LFVN |
Lifevantage Corporation |
Director |
– • – |
2011-12-05 |
4 |
S |
$1.44 |
$81,797 |
D/D |
(56,934) |
676,441 |
0 |
- |
|
| LFVN |
Lifevantage Corporation |
Director |
– • – |
2011-12-02 |
4 |
S |
$1.45 |
$23,856 |
D/D |
(16,500) |
733,375 |
0 |
- |
|
| OMBP |
Omni Bio Pharmaceutical |
CEO |
• • – |
2011-06-27 |
4 |
B |
$0.00 |
$0 |
D/D |
40,000 |
340,000 |
2.73 |
- |
|
| LFVN |
Lifevantage Corporation |
Director |
– • – |
2011-05-26 |
4 |
OE |
$0.20 |
$24,975 |
D/D |
124,875 |
749,875 |
0 |
- |
|
| OMBP |
Omni Bio Pharmaceutical |
CEO |
• – – |
2011-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
0 |
- |
|
| LFVN |
Lifevantage Corporation |
Director |
– • – |
2009-04-07 |
4 |
B |
$0.20 |
$10,000 |
D/D |
50,000 |
625,000 |
2.39 |
- |
|
| LFVN |
Lifevantage Corporation |
Director |
– • – |
2005-07-06 |
4 |
B |
$1.36 |
$748,000 |
D/D |
550,000 |
575,000 |
2.39 |
- |
|
| LFVN |
Lifevantage Corporation |
Director |
– • – |
2005-05-16 |
4 |
B |
$2.00 |
$50,000 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Chief Executive OfficerOfficer |
• – – |
2004-07-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
67,000 |
|
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Chief Executive OfficerOfficer |
• – – |
2004-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
724,951 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
